United States Biotechnology & Medical Research

Xeris Biopharma Holdings Inc (XERS)

Track

Track

Xeris Biopharma Holdings Inc. experienced fifteen insider trading transactions over the past ninety days, all involving sales totaling approximately 3.74 million dollars. Key executives, including Kevin McCulloch, Beth Hecht, and Steven Pieper, executed these planned divestments. This activity follows the company's recent results financiers, where earnings missed expectations by 150 percent.
Ticker: XERS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Xeris Biopharma Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders

Similar companies

View all Biotechnology & Medical Research companies
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
354.98
Quantity 19,470 +16.9%
Value US$2,100,966
3.7
Pieper Steven See Remarks Officer
Transaction date
Planned sale
Price
357.71
Quantity 78,291 +0.8%
Value US$3,837,370
3.4
McCulloch Kevin See Remarks Officer
Transaction date
Planned sale
Price
434.36
Quantity 59,771 -32.2%
Value US$234,615
3.7
Pieper Steven See Remarks Officer
Transaction date
Planned sale
Price
8.50
Quantity 5,000 -0.4%
Value US$42,500
3.7
STEVEN PIEPER Officer Officer
Transaction date
Proposed sale
Price
8.39
Quantity 20,000
Value US$167,800
3.4
McCulloch Kevin See Remarks Officer
Transaction date
Planned sale
Price
8.02
Quantity 15,000 -0.9%
Value US$120,240
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
8.01
Quantity 16,666 -1.4%
Value US$133,553
3.7
Pieper Steven See Remarks Officer
Transaction date
Planned sale
Price
8.52
Quantity 27,600 -2.0%
Value US$235,276
3.7
STEVEN PIEPER Officer Officer
Transaction date
Proposed sale
Price
8.37
Quantity 27,600
Value US$231,012
3.7
Pieper Steven See Remarks Officer
Transaction date
Planned sale
Price
8.50
Quantity 17,400 -1.2%
Value US$147,900
3.7
STEVEN PIEPER Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 17,400
Value US$144,072
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
8.03
Quantity 16,666 -1.4%
Value US$133,860
3.4
McCulloch Kevin See Remarks Officer
Transaction date
Planned sale
Price
8.03
Quantity 90,000 -5.1%
Value US$722,511
3.1
BETH HECHT Officer Officer
Transaction date
Proposed sale
Price
7.92
Quantity 49,998
Value US$395,984
3.4
KEVIN MCCULLOCH Officer Officer
Transaction date
Proposed sale
Price
7.92
Quantity 120,000
Value US$950,400
3.1
JOHNSON JOHN Non-Executive Director
Transaction date
Planned sale
Price
6.09
Quantity 15,000 -2.1%
Value US$91,422
2.7
HALKUFF DAWN Non-Executive Director
Transaction date
Planned sale
Price
6.09
Quantity 20,000 -17.4%
Value US$121,886
2.7
DAWN HALKUFF Director Non-Executive Director
Transaction date
Proposed sale
Price
5.89
Quantity 20,000
Value US$117,800
3.1
JOHN H JOHNSON Director Non-Executive Director
Transaction date
Proposed sale
Price
5.89
Quantity 15,000
Value US$88,350
Barbara-Jean Bormann-Kennedy Director Non-Executive Director
Transaction date
Proposed sale
Price
5.89
Quantity 16,000
Value US$94,240
3.3
PERSKY MARLA Non-Executive Director
Transaction date
Planned sale
Price
5.90
Quantity 15,500 -10.9%
Value US$91,433
3.3
MARLA PERSKY Director Non-Executive Director
Transaction date
Proposed sale
Price
6.00
Quantity 15,500
Value US$93,000
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
6.06
Quantity 16,667 -1.4%
Value US$100,982
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
6.23
Quantity 16,667 -1.4%
Value US$103,805
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
5.99
Quantity 16,667 -1.4%
Value US$99,859
Brady James Aloysius Non-Executive Director
Transaction date
Planned sale
Price
5.54
Quantity 10,834 -10.8%
Value US$60,036
JAMES BRADY Director Non-Executive Director
Transaction date
Proposed sale
Price
5.40
Quantity 10,834
Value US$58,504
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
7.06
Quantity 100 -0.0%
Value US$706
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
6.24
Quantity 16,567 -1.3%
Value US$103,380
3.1
BETH HECHT Officer Officer
Transaction date
Proposed sale
Price
6.12
Quantity 66,668
Value US$408,008
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
7.45
Quantity 16,667 -1.3%
Value US$124,147
3.4
McCulloch Kevin See Remarks Officer
Transaction date
Planned sale
Price
8.00
Quantity 15,000 -0.9%
Value US$120,000
3.4
KEVIN MCCULLOCH Officer Officer
Transaction date
Proposed sale
Price
7.21
Quantity 60,000
Value US$432,600
3.8
Shannon John Patrick Jr See Remarks Executive Director
Transaction date
Planned sale
Price
7.08
Quantity 24,907 -0.9%
Value US$176,257
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
7.43
Quantity 16,667 -1.3%
Value US$123,776
3.1
JOHN H JOHNSON Director Non-Executive Director
Transaction date
Proposed sale
Price
7.22
Quantity 135,402
Value US$977,034
3.1
JOHNSON JOHN Non-Executive Director
Transaction date
Sale
Price
7.22
Quantity 135,400 -16.2%
Value US$977,019
BARBARA-JEAN A BORMANN-KENNEDY Director Non-Executive Director
Transaction date
Proposed sale
Price
7.01
Quantity 15,000
Value US$105,150
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
7.01
Quantity 16,667 -1.2%
Value US$116,781
3.8
Shannon John Patrick Jr See Remarks Executive Director
Transaction date
Planned sale
Price
7.46
Quantity 23,242 -0.9%
Value US$173,402
3.8
JOHN SHANNON Director; Officer Executive Director
Transaction date
Proposed sale
Price
7.59
Quantity 48,149
Value US$365,451
3.1
Hecht Beth See Remarks Officer
Transaction date
Planned sale
Price
7.40
Quantity 16,667 -1.2%
Value US$123,296
3.1
BETH HECHT Officer Officer
Transaction date
Proposed sale
Price
7.72
Quantity 66,668
Value US$514,677
3.3
PERSKY MARLA Non-Executive Director
Transaction date
Planned sale
Price
7.72
Quantity 15,500 -9.8%
Value US$119,610
3.3
MARLA PERSKY Director Non-Executive Director
Transaction date
Proposed sale
Price
7.81
Quantity 15,500
Value US$121,055
3.0
SHERMAN JEFFREY W Non-Executive Director
Transaction date
Sale
Price
7.92
Quantity 42,232 -16.2%
Value US$334,515
3.0
JEFFREY SHERMAN Director Non-Executive Director
Transaction date
Proposed sale
Price
7.92
Quantity 42,232
Value US$334,511
3.1
JOHNSON JOHN Non-Executive Director
Transaction date
Sale
Price
7.32
Quantity 107,500 -11.4%
Value US$786,459
3.1
JOHN H JOHNSON Director Non-Executive Director
Transaction date
Proposed sale
Price
7.32
Quantity 107,500
Value US$786,452
2.7
HALKUFF DAWN Non-Executive Director
Transaction date
Sale
Price
7.28
Quantity 42,500 -27.0%
Value US$309,226
2.7
DAWN HALKUFF Director Non-Executive Director
Transaction date
Proposed sale
Price
7.28
Quantity 42,500
Value US$309,226
3.4
McCulloch Kevin See Remarks Officer
Transaction date
Purchase
Price
4.38
Quantity 25,000 +1.5%
Value US$109,475
Fairley Ricki Louise Director Non-Executive Director
Transaction date
Proposed sale
Price
4.90
Quantity 56,667
Value US$277,668
3.1
Hecht Beth See Remarks Officer
Transaction date
Sale
Price
5.43
Quantity 40,000 -2.9%
Value US$217,244
3.1
Hecht Beth Officer Officer
Transaction date
Proposed sale
Price
5.14
Quantity 40,000
Value US$205,600
1.9
Schmid John P. Non-Executive Director
Transaction date
Purchase
Price
2.25
Quantity 4,515 +21.8%
Value US$10,147
1.9
Schmid John P. Non-Executive Director
Transaction date
Purchase
Price
2.37
Quantity 4,285 +26.1%
Value US$10,134
1.9
Schmid John P. Non-Executive Director
Transaction date
Purchase
Price
1.91
Quantity 5,400 +49.1%
Value US$10,314
1.9
Schmid John P. Non-Executive Director
Transaction date
Purchase
Price
1.91
Quantity 5,400 +49.1%
Value US$10,314
1.9
Schmid John P. Non-Executive Director
Transaction date
Purchase
Price
2.16
Quantity 4,500 +69.2%
Value US$9,720
3.0
SHERMAN JEFFREY W Non-Executive Director
Transaction date
Purchase
Price
1.87
Quantity 5,400 +inf%
Value US$10,098
3.7
Pieper Steven See Remarks Officer
Transaction date
Purchase
Price
1.95
Quantity 28,000 +2.4%
Value US$54,600
2.7
HALKUFF DAWN Non-Executive Director
Transaction date
Purchase
Price
1.84
Quantity 5,410 +inf%
Value US$9,954
3.8
Shannon John Patrick Jr See Remarks Officer
Transaction date
Purchase
Price
1.64
Quantity 30,769 +2.2%
Value US$50,400
1.9
Schmid John P. Non-Executive Director
Transaction date
Purchase
Price
1.51
Quantity 6,500 +inf%
Value US$9,815
3.3
PERSKY MARLA Non-Executive Director
Transaction date
Purchase
Price
1.58
Quantity 6,370 +inf%
Value US$10,058
3.8
Edick Paul R See Remarks Executive Director
Transaction date
Purchase
Price
2.38
Quantity 10,000 +0.4%
Value US$23,794
3.8
Edick Paul R See Remarks Executive Director
Transaction date
Purchase
Price
1.45
Quantity 20,000 +1.3%
Value US$29,000
3.8
Edick Paul R See Remarks Executive Director
Transaction date
Purchase
Price
1.40
Quantity 100,000 +7.1%
Value US$140,380
PRESTRELSKI STEVEN Chief Scientific Officer Officer
Transaction date
Planned sale
Price
2.42
Quantity 11,228 -1.9%
Value US$27,158
3.8
Edick Paul R See Remarks Executive Director
Transaction date
Purchase
Price
2.28
Quantity 20,000 +148.9%
Value US$45,664
3.8
Shannon John Patrick Jr See Remarks Officer
Transaction date
Purchase
Price
2.10
Quantity 60,000 +19.7%
Value US$126,000
3.8
Edick Paul R See Remarks Executive Director
Transaction date
Purchase
Price
2.08
Quantity 200,000 +32.9%
Value US$415,760
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-01 2026-09-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
19,470 +16.9%
354.98
US$2,100,966 		19,470 +16.9% 354.98 US$2,100,966
2026-09-01 2026-09-01 PlS Planned sale
3.7
Pieper Steven

See Remarks

Officer
78,291 +0.8%
357.71
US$3,837,370 		78,291 +0.8% 357.71 US$3,837,370
2026-09-01 2026-09-01 PlS Planned sale
3.4
McCulloch Kevin

See Remarks

Officer
59,771 -32.2%
434.36
US$234,615 		59,771 -32.2% 434.36 US$234,615
2026-08-12 2026-08-12 PlS Planned sale
3.7
Pieper Steven

See Remarks

Officer
5,000 -0.4%
8.50
US$42,500 		5,000 -0.4% 8.50 US$42,500
2026-08-12 2026-08-12 PrS Proposed sale
3.7
STEVEN PIEPER

Officer

Officer
20,000
8.39
US$167,800 		20,000 8.39 US$167,800
2026-08-04 2026-08-03 PlS Planned sale
3.4
McCulloch Kevin

See Remarks

Officer
15,000 -0.9%
8.02
US$120,240 		15,000 -0.9% 8.02 US$120,240
2026-08-04 2026-08-03 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,666 -1.4%
8.01
US$133,553 		16,666 -1.4% 8.01 US$133,553
2026-07-07 2026-07-07 PlS Planned sale
3.7
Pieper Steven

See Remarks

Officer
27,600 -2.0%
8.52
US$235,276 		27,600 -2.0% 8.52 US$235,276
2026-07-07 2026-07-07 PrS Proposed sale
3.7
STEVEN PIEPER

Officer

Officer
27,600
8.37
US$231,012 		27,600 8.37 US$231,012
2026-07-07 2026-07-06 PlS Planned sale
3.7
Pieper Steven

See Remarks

Officer
17,400 -1.2%
8.50
US$147,900 		17,400 -1.2% 8.50 US$147,900
2026-07-06 2026-07-06 PrS Proposed sale
3.7
STEVEN PIEPER

Officer

Officer
17,400
8.28
US$144,072 		17,400 8.28 US$144,072
2026-07-02 2026-07-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,666 -1.4%
8.03
US$133,860 		16,666 -1.4% 8.03 US$133,860
2026-07-02 2026-07-01 PlS Planned sale
3.4
McCulloch Kevin

See Remarks

Officer
90,000 -5.1%
8.03
US$722,511 		90,000 -5.1% 8.03 US$722,511
2026-07-01 2026-07-01 PrS Proposed sale
3.1
BETH HECHT

Officer

Officer
49,998
7.92
US$395,984 		49,998 7.92 US$395,984
2026-07-01 2026-07-01 PrS Proposed sale
3.4
KEVIN MCCULLOCH

Officer

Officer
120,000
7.92
US$950,400 		120,000 7.92 US$950,400
2026-06-05 2026-06-04 PlS Planned sale
BORMANN-KENNEDY BARBARA-JEAN ANNE
Non-Executive Director
16,000 -11.2%
6.09
US$97,507 		16,000 -11.2% 6.09 US$97,507
2026-06-05 2026-06-04 PlS Planned sale
3.1
JOHNSON JOHN
Non-Executive Director
15,000 -2.1%
6.09
US$91,422 		15,000 -2.1% 6.09 US$91,422
2026-06-05 2026-06-04 PlS Planned sale
2.7
HALKUFF DAWN
Non-Executive Director
20,000 -17.4%
6.09
US$121,886 		20,000 -17.4% 6.09 US$121,886
2026-06-04 2026-06-04 PrS Proposed sale
2.7
DAWN HALKUFF

Director

Non-Executive Director
20,000
5.89
US$117,800 		20,000 5.89 US$117,800
2026-06-04 2026-06-04 PrS Proposed sale
3.1
JOHN H JOHNSON

Director

Non-Executive Director
15,000
5.89
US$88,350 		15,000 5.89 US$88,350
2026-06-04 2026-06-04 PrS Proposed sale
Barbara-Jean Bormann-Kennedy

Director

Non-Executive Director
16,000
5.89
US$94,240 		16,000 5.89 US$94,240
2026-06-05 2026-06-03 PlS Planned sale
3.3
PERSKY MARLA
Non-Executive Director
15,500 -10.9%
5.90
US$91,433 		15,500 -10.9% 5.90 US$91,433
2026-06-03 2026-06-03 PrS Proposed sale
3.3
MARLA PERSKY

Director

Non-Executive Director
15,500
6.00
US$93,000 		15,500 6.00 US$93,000
2026-06-02 2026-06-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.4%
6.06
US$100,982 		16,667 -1.4% 6.06 US$100,982
2026-05-01 2026-05-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.4%
6.23
US$103,805 		16,667 -1.4% 6.23 US$103,805
2026-04-03 2026-04-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.4%
5.99
US$99,859 		16,667 -1.4% 5.99 US$99,859
2026-04-01 2026-03-30 PlS Planned sale
Brady James Aloysius
Non-Executive Director
10,834 -10.8%
5.54
US$60,036 		10,834 -10.8% 5.54 US$60,036
2026-03-30 2026-03-30 PrS Proposed sale
JAMES BRADY

Director

Non-Executive Director
10,834
5.40
US$58,504 		10,834 5.40 US$58,504
2026-03-04 2026-03-02 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
100 -0.0%
7.06
US$706 		100 -0.0% 7.06 US$706
2026-03-04 2026-03-02 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,567 -1.3%
6.24
US$103,380 		16,567 -1.3% 6.24 US$103,380
2026-03-02 2026-03-02 PrS Proposed sale
3.1
BETH HECHT

Officer

Officer
66,668
6.12
US$408,008 		66,668 6.12 US$408,008
2026-02-02 2026-02-02 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.3%
7.45
US$124,147 		16,667 -1.3% 7.45 US$124,147
2026-01-09 2026-01-08 PlS Planned sale
3.4
McCulloch Kevin

See Remarks

Officer
15,000 -0.9%
8.00
US$120,000 		15,000 -0.9% 8.00 US$120,000
2026-01-08 2026-01-08 PrS Proposed sale
3.4
KEVIN MCCULLOCH

Officer

Officer
60,000
7.21
US$432,600 		60,000 7.21 US$432,600
2026-01-06 2026-01-05 PlS Planned sale
3.8
Shannon John Patrick Jr

See Remarks

Executive Director
24,907 -0.9%
7.08
US$176,257 		24,907 -0.9% 7.08 US$176,257
2026-01-05 2026-01-02 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.3%
7.43
US$123,776 		16,667 -1.3% 7.43 US$123,776
2025-12-19 2025-12-19 PrS Proposed sale
3.1
JOHN H JOHNSON

Director

Non-Executive Director
135,402
7.22
US$977,034 		135,402 7.22 US$977,034
2025-12-19 2025-12-19 S Sale
3.1
JOHNSON JOHN
Non-Executive Director
135,400 -16.2%
7.22
US$977,019 		135,400 -16.2% 7.22 US$977,019
2025-12-15 2025-12-12 PlS Planned sale
BORMANN-KENNEDY BARBARA-JEAN ANNE
Non-Executive Director
15,000 -9.5%
7.09
US$106,414 		15,000 -9.5% 7.09 US$106,414
2025-12-12 2025-12-12 PrS Proposed sale
BARBARA-JEAN A BORMANN-KENNEDY

Director

Non-Executive Director
15,000
7.01
US$105,150 		15,000 7.01 US$105,150
2025-12-02 2025-12-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.2%
7.01
US$116,781 		16,667 -1.2% 7.01 US$116,781
2025-11-17 2025-11-13 PlS Planned sale
3.8
Shannon John Patrick Jr

See Remarks

Executive Director
23,242 -0.9%
7.46
US$173,402 		23,242 -0.9% 7.46 US$173,402
2025-11-13 2025-11-13 PrS Proposed sale
3.8
JOHN SHANNON

Director; Officer

Executive Director
48,149
7.59
US$365,451 		48,149 7.59 US$365,451
2025-11-13 2025-11-11 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.2%
7.40
US$123,296 		16,667 -1.2% 7.40 US$123,296
2025-11-12 2025-11-11 PrS Proposed sale
3.1
BETH HECHT

Officer

Officer
66,668
7.72
US$514,677 		66,668 7.72 US$514,677
2025-09-12 2025-09-11 PlS Planned sale
3.3
PERSKY MARLA
Non-Executive Director
15,500 -9.8%
7.72
US$119,610 		15,500 -9.8% 7.72 US$119,610
2025-09-11 2025-09-11 PrS Proposed sale
3.3
MARLA PERSKY

Director

Non-Executive Director
15,500
7.81
US$121,055 		15,500 7.81 US$121,055
2025-08-29 2025-08-28 S Sale
3.0
SHERMAN JEFFREY W
Non-Executive Director
42,232 -16.2%
7.92
US$334,515 		42,232 -16.2% 7.92 US$334,515
2025-08-28 2025-08-28 PrS Proposed sale
3.0
JEFFREY SHERMAN

Director

Non-Executive Director
42,232
7.92
US$334,511 		42,232 7.92 US$334,511
2025-08-15 2025-08-13 S Sale
3.1
JOHNSON JOHN
Non-Executive Director
107,500 -11.4%
7.32
US$786,459 		107,500 -11.4% 7.32 US$786,459
2025-08-13 2025-08-13 PrS Proposed sale
3.1
JOHN H JOHNSON

Director

Non-Executive Director
107,500
7.32
US$786,452 		107,500 7.32 US$786,452
2025-08-13 2025-08-12 S Sale
2.7
HALKUFF DAWN
Non-Executive Director
42,500 -27.0%
7.28
US$309,226 		42,500 -27.0% 7.28 US$309,226
2025-08-12 2025-08-12 PrS Proposed sale
2.7
DAWN HALKUFF

Director

Non-Executive Director
42,500
7.28
US$309,226 		42,500 7.28 US$309,226
2025-06-16 2025-06-13 B Purchase
3.4
McCulloch Kevin

See Remarks

Officer
25,000 +1.5%
4.38
US$109,475 		25,000 +1.5% 4.38 US$109,475
2025-05-09 2025-05-09 PrS Proposed sale
Fairley Ricki Louise

Director

Non-Executive Director
56,667
4.90
US$277,668 		56,667 4.90 US$277,668
2025-03-21 2025-03-20 S Sale
3.1
Hecht Beth

See Remarks

Officer
40,000 -2.9%
5.43
US$217,244 		40,000 -2.9% 5.43 US$217,244
2025-03-20 2025-03-20 PrS Proposed sale
3.1
Hecht Beth

Officer

Officer
40,000
5.14
US$205,600 		40,000 5.14 US$205,600
2024-08-13 2024-08-12 B Purchase
1.9
Schmid John P.
Non-Executive Director
4,515 +21.8%
2.25
US$10,147 		4,515 +21.8% 2.25 US$10,147
2024-08-12 2024-08-09 B Purchase
1.9
Schmid John P.
Non-Executive Director
4,285 +26.1%
2.37
US$10,134 		4,285 +26.1% 2.37 US$10,134
2024-05-10 2024-05-10 B Purchase
1.9
Schmid John P.
Non-Executive Director
5,400 +49.1%
1.91
US$10,314 		5,400 +49.1% 1.91 US$10,314
2024-05-10 2024-05-10 B Purchase
1.9
Schmid John P.
Non-Executive Director
5,400 +49.1%
1.91
US$10,314 		5,400 +49.1% 1.91 US$10,314
2024-03-14 2024-03-14 B Purchase
1.9
Schmid John P.
Non-Executive Director
4,500 +69.2%
2.16
US$9,720 		4,500 +69.2% 2.16 US$9,720
2023-11-29 2023-11-27 B Purchase
3.0
SHERMAN JEFFREY W
Non-Executive Director
5,400 +inf%
1.87
US$10,098 		5,400 +inf% 1.87 US$10,098
2023-11-21 2023-11-20 B Purchase
3.7
Pieper Steven

See Remarks

Officer
28,000 +2.4%
1.95
US$54,600 		28,000 +2.4% 1.95 US$54,600
2023-11-21 2023-11-20 B Purchase
2.7
HALKUFF DAWN
Non-Executive Director
5,410 +inf%
1.84
US$9,954 		5,410 +inf% 1.84 US$9,954
2023-11-17 2023-11-17 B Purchase
3.8
Shannon John Patrick Jr

See Remarks

Officer
30,769 +2.2%
1.64
US$50,400 		30,769 +2.2% 1.64 US$50,400
2023-11-17 2023-11-16 B Purchase
1.9
Schmid John P.
Non-Executive Director
6,500 +inf%
1.51
US$9,815 		6,500 +inf% 1.51 US$9,815
2023-11-15 2023-11-14 B Purchase
3.3
PERSKY MARLA
Non-Executive Director
6,370 +inf%
1.58
US$10,058 		6,370 +inf% 1.58 US$10,058
2023-08-09 2023-08-09 B Purchase
3.8
Edick Paul R

See Remarks

Executive Director
10,000 +0.4%
2.38
US$23,794 		10,000 +0.4% 2.38 US$23,794
2022-12-14 2022-12-13 B Purchase
3.8
Edick Paul R

See Remarks

Executive Director
20,000 +1.3%
1.45
US$29,000 		20,000 +1.3% 1.45 US$29,000
2022-05-13 2022-05-12 B Purchase
3.8
Edick Paul R

See Remarks

Executive Director
100,000 +7.1%
1.40
US$140,380 		100,000 +7.1% 1.40 US$140,380
2022-02-24 2022-02-22 PlS Planned sale
PRESTRELSKI STEVEN

Chief Scientific Officer

Officer
11,228 -1.9%
2.42
US$27,158 		11,228 -1.9% 2.42 US$27,158
2021-11-16 2021-11-15 B Purchase
3.8
Edick Paul R

See Remarks

Executive Director
20,000 +148.9%
2.28
US$45,664 		20,000 +148.9% 2.28 US$45,664
2021-11-12 2021-11-12 B Purchase
3.8
Shannon John Patrick Jr

See Remarks

Officer
60,000 +19.7%
2.10
US$126,000 		60,000 +19.7% 2.10 US$126,000
2021-11-12 2021-11-11 B Purchase
3.8
Edick Paul R

See Remarks

Executive Director
200,000 +32.9%
2.08
US$415,760 		200,000 +32.9% 2.08 US$415,760
Explore more

More insider trading research around Xeris Biopharma Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America